VTVT News and Press, vTv Therapeutics Inc. From 06/28/19

InsiderInsights' Daily Round-Up articles rate the "significance" of the top 10 dollar value insider purchases and sales filed at the SEC on the Title date. Dollar value is only the most basic metric to assess the significance of an insider transaction, however, and there are many more "Signifi...

vTv Therapeutics Inc. (Nasdaq: VTVT) announced today that the first patient has been screened for the phase 2 proof of concept study evaluating the safety and efficacy of azeliragon in patients with mild Alzheimer's disease and type 2 diabetes. In a post hoc analysis of the phase 3 STEA...

Let's spell Biogen Buy-o-Gen. Indeed, BIIB seems increasingly appealing at current price. The biotech focuses on discovering, developing, and delivering therapies to people living with serious neurological, rare and autoimmune diseases. The Company markets various products for multiple sc...

Company Overview vTv Therapeutics (NASDAQ: VTVT) is a clinical-stage biopharmaceutical company engaged in the discovery and development of orally-administered small molecule drug candidates. The firm has a pipeline of 7 clinical drug candidates, all in Phase 1 and 2. Azeliragon (TTP488), an ...

ContraVir Pharmaceuticals (NASDAQ: CTRV ) +123%  on encouraging CRV431 data . More news on: ContraVir Pharmaceuticals, Inc., Stitch Fix, Inc., Ciena Corporation, Stocks on the move, Read more ...

TTP399, a novel glucokinase activator shows statistically significant reduction in HbA1c without increases in ketones or hypoglycemia vTv Therapeutics Inc. (Nasdaq: VTVT) today announced positive results from the primary analysis of Part 1 of the Phase 2 Simplici-T1 trial assessing ...

Obalon Therapeutics (NASDAQ: OBLN ) +24% . More news on: Obalon Therapeutics, Inc., Keysight Technologies, Inc., Burlington Stores, Inc., Stocks on the move, Read more ...

InsiderInsights' Daily Round Up articles rate the "significance" of the top 10 dollar value insider purchases and sales filed at the SEC on the Title date. Dollar value is only the most basic metric to assess the significance of an insider transaction, however, and there are many more "Signifi...

Iovance Biotherapeutics (NASDAQ: IOVA ) +36%  on positive TIL data . More news on: Iovance Biotherapeutics, Inc., CUI Global, Inc., MacroGenics, Inc., Stocks on the move, Read more ...

vTv Therapeutics (NASDAQ: VTVT ): Q1 Non-GAAP EPS of -$0.09; GAAP EPS of -$0.26. More news on: vTv Therapeutics Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...